Clinical Trials Directory

Trials / Completed

CompletedNCT00038558

Prophylactic Use of Filgrastim SD/01 in Patients With Hodgkin's Disease Receiving ABVD Chemotherapy

Prophylactic Use of Filgrastim SD/01 In Patients With Hodgkin's Disease Receiving ABVD Chemotherapy

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
25 (actual)
Sponsor
M.D. Anderson Cancer Center · Academic / Other
Sex
All
Age
16 Years
Healthy volunteers
Not accepted

Summary

Prophylactic use of Filgrastim SD/01 for patients with Hodgkin's lymphoma receiving ABVD chemotherapy.

Conditions

Interventions

TypeNameDescription
DRUGFilgrastim SD/01
DRUGAdriamycin
DRUGBleomycin
DRUGVinblastine
DRUGDTIC

Timeline

Start date
2001-11-01
Primary completion
2004-02-01
Completion
2005-03-01
First posted
2002-06-03
Last updated
2018-10-31

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00038558. Inclusion in this directory is not an endorsement.

Prophylactic Use of Filgrastim SD/01 in Patients With Hodgkin's Disease Receiving ABVD Chemotherapy (NCT00038558) · Clinical Trials Directory